Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last SR36.56 SAR
Change Today +0.06 / 0.16%
Volume 571.0K
As of 9:30 AM 08/27/15 All times are local (Market data is delayed by at least 15 minutes).

saudi pharmaceutical industr (SPIMACO) Snapshot

Open
SR37.50
Previous Close
SR36.50
Day High
SR38.00
Day Low
SR36.50
52 Week High
09/9/14 - SR55.25
52 Week Low
12/17/14 - SR27.60
Market Cap
4.4B
Average Volume 10 Days
693.9K
EPS TTM
SR3.88
Shares Outstanding
120.0M
EX-Date
04/26/15
P/E TM
9.4x
Dividend
SR1.50
Dividend Yield
4.10%
Current Stock Chart for SAUDI PHARMACEUTICAL INDUSTR (SPIMACO)

Related News

No related news articles were found.

saudi pharmaceutical industr (SPIMACO) Related Businessweek News

No Related Businessweek News Found

saudi pharmaceutical industr (SPIMACO) Details

Saudi Pharmaceutical Industries & Medical Appliances Corporation develops, manufactures, and sells pharmaceutical products and medical appliances in the Kingdom of Saudi Arabia and internationally. It provides anti allergic, antifungal, antiviral, bronchodilator, cardiovascular, anti diabetic, gastrointestinal, and antibiotic drugs; cold and cough preparations; and nasal decongestant products. The company offers its products in various dosage forms comprising tablets and capsules, dry powder, syrups, suspensions, injections, creams, ointments, gels, suppositories, and mouthwash and antiseptic products. Saudi Pharmaceutical Industries & Medical Appliances Corporation was founded in 1986 and is based in Riyadh, the Kingdom of Saudi Arabia.

Founded in 1986

saudi pharmaceutical industr (SPIMACO) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

saudi pharmaceutical industr (SPIMACO) Key Developments

Saudi Pharmaceutical Industries & Medical Appliances Corporation Reports Unaudited Consolidated Financial Results for the Second Quarter and Six Months Ended June 30, 2015

Saudi Pharmaceutical Industries & Medical Appliances Corporation reported unaudited consolidated financial results for the second quarter and six months ended June 30, 2015. For the quarter, the company reported operating profit of SAR 48 million against SAR 42.6 million for the same period of last year. Net profit was SAR 237.6 million against SAR 97.7 million for the same period of last year. For the six months, the company reported operating profit of SAR 139.4 million against SAR 121 million for the same period of last year. Net profit was SAR 337 million or SAR 2.81 per share against SAR 188.9 million or SAR 1.98 per share for the same period of last year. Sales rose by 16% in addition to the net capital gains due to sell its entire stake in Eirgen Pharma for Opko at total value of SR 151.3 million, which after deducting the costs and expenses of the legal and financial agreements.

Saudi Pharmaceutical Industries & Medical Appliances Corporation Announces Earnings Results for the First Quarter Ended March 31, 2015

Saudi Pharmaceutical Industries & Medical Appliances Corporation announced earnings results for the first quarter ended March 31, 2015. For the period, the company reported that net profit was SAR 99.4 million or SAR 0.83 per share, compared to SAR 91.2 million, or SAR 1.16 per share, for the same quarter ended March 31, 2014. Operational profit was SAR 91.3 million, compared to SAR 76.1 million for the same quarter ended March 31, 2014.

Saudi Pharmaceutical Industries & Medical Appliances Corporation Recommends Dividend for the Year 2014

The Board of Directors of Saudi Pharmaceutical Industries & Medical Appliances Corporation has recommended distribution of cash dividend of SAR 1.5 per share to stockholders for financial year 2014. Total amount of distribution of dividend SAR 180 million.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SPIMACO:AB SR36.56 SAR +0.06

SPIMACO Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for SPIMACO.
View Industry Companies
 

Industry Analysis

SPIMACO

Industry Average

Valuation SPIMACO Industry Range
Price/Earnings 9.4x
Price/Sales 2.8x
Price/Book 1.3x
Price/Cash Flow 9.4x
TEV/Sales 2.6x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SAUDI PHARMACEUTICAL INDUSTR, please visit www.spimaco.com.sa. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.